Maycur, Shouhoubao Named "Future Unicorns" of Hangzhou 2022 | Oasis Vitality
Recently, the 6th Wanwu Growth Conference was held in Hangzhou, co-hosted by the Hangzhou Municipal People's Government, the Zhejiang Provincial Committee of the China Democratic National Construction Association, and the China Investment Development Promotion Association, under the guidance of the China Association for Science and Technology. At the conference, Weilian, a one-stop industrial innovation service platform, jointly released the "2022 Hangzhou Unicorn & Future Unicorn Enterprise List" with the Hangzhou Venture Capital Association. Among the future unicorn enterprises on the 2022 list, the healthcare sector ranked first with 84 companies, accounting for 26% of the total.
Recently, the 6th Wanwu Growth Conference — guided by the China Association for Science and Technology and co-hosted by the Hangzhou Municipal Government, the Zhejiang Provincial Committee of the China Democratic National Construction Association, and the China Investment Development Promotion Association — was held in Hangzhou. At the conference, Weilian, a one-stop industrial innovation service platform, jointly released the "2022 Hangzhou Unicorn & Future Unicorn Enterprise List" with the Hangzhou Venture Capital Association. Among the 2022 Future Unicorn enterprises, healthcare ranked first with 84 companies, accounting for 26.5% — nearly a 50% increase from 2021, representing a "major breakout" in both capital attention and company count. Enterprise services, advanced manufacturing, AI, and e-commerce ranked second through fifth respectively. In terms of sector shifts, 131 new Future Unicorns were added in 2022, with the top five growth sectors being healthcare (29%), advanced manufacturing (23.66%), enterprise services (14.5%), AI (9.16%), and big data (8.4%). Notably, two Oasis Capital portfolio companies — Maycur and Shouhoubao — were named 2022 Hangzhou Future Unicorns in enterprise services.
The world changes endlessly, and the noise is overwhelming. Oasis Capital will continue to adhere to a "top-down" research methodology, combining the experience of ecosystem entrepreneurs to deliver sustained signals for the long term. We remain anchored in "demographics" and "technology innovation" as our entry points, focusing on technology-enabled services in healthcare and enterprise services, and making long-term investments in the most vital entrepreneurs. Celebrating Vitality.
Oasis Capital is a new-generation Chinese venture capital firm dedicated to discovering the most vital entrepreneurs of the next decade in China, growing alongside them, and creating long-term value. "Celebrating Vitality" is Oasis Capital's vision and mission. This vitality is both the direction of structural transformation in our era and the force of resilience and evolution within entrepreneurs.
Oasis Capital focuses on early and growth-stage investments, with check sizes ranging from $3 million to $30 million, concentrating on technology-enabled services in healthcare, enterprise services, and related sectors, supporting China's technology-driven new services upgrade.
